Ledger.Open graph →
SEC Form D · Amendment · filed March 22, 2019

Alvarado Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James A. Lillie · San Francisco, CAExecChristopher A. Kroeger · San Francisco, CAExec · DirectorGeorge A. Pavlov · San Francisco, CADirectorGeorge A. Pavlov · San Francisco, CADirectorPeter A. Bisgaard · Lexington, MADirectorChristopher A. Kroeger · Marlborough, MAExec · DirectorRobert A. Malenka · San Francisco, CADirectorJonathan A. Gillis · San Francisco, CAExecJonathan A. Gillis · San Francisco, CAExecJames A. Lillie · San Francisco, CAExecRobert A. Malenka · San Francisco, CADirectorPeter A. Bisgaard · Lexington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗